Will the Iran War Become the Poison Pill for Proxy Contests This Season?

Escalating hostilities in the Middle East have injected a new layer of geopolitical risk into already fragile capital markets. The effects of oil price volatility, supply chain disruption, cyberthreats, and heightened regulatory scrutiny are rippling across industries. As with tariffs last year, geopolitical shocks do not affect only a company’s operating performance; they also directly alter the risk calculus for shareholder activists. While the ultimate geopolitical trajectory remains uncertain, the immediate question for Corporate America is more tactical: Will the Iran war chill proxy contests this season?

Timing Is Everything in Proxy Season

Most U.S. public companies hold annual meetings in April, May, or June. Because advance-notice bylaws typically require director nominations 90 days earlier, this is the time of year when activists must decide whether to “put up or shut up.”

Launching a proxy contest is not a short-term trade. As a practical matter, activists must be prepared to hold their position at least through the annual meeting and, if successful, for six to 12 months thereafter. Exiting quickly after launching a contest — or even after winning board seats — undermines the credibility of an activist. Activists are repeat players who cannot afford a reputation as a “quitter.”

Geopolitical instability complicates these commitments.

The Activist’s Dilemma in a Geopolitical Crisis

A geopolitical conflict introduces risks that are difficult to price or hedge. These risks include

• energy price spikes creating bottlenecks in critical sectors (e.g., industrials, transportation, chemicals, and consumer)

• cybersecurity threats targeting financial institutions and infrastructure

• supply chain disruption in sensitive geographies

• potential sanctions affecting cross-border operations

• increased defense spending and regulatory complexity

Unlike company-specific underperformance, geopolitical shocks are macroeconomic in nature and largely outside management’s control. That makes it harder for activists to frame an underperformance thesis around governance or strategy.

More important, activists contemplating a proxy fight must assume they will be locked into the stock during a period of potential market dislocation. When an activist’s available dry powder declines rapidly, it becomes harder to move into and out of an investment position. This is even more true if an activist has access to material nonpublic information, as that significantly restricts trading flexibility and eliminates the option to “cut and run” if geopolitical events deteriorate.

In volatile markets driven by war-related developments, that lack of liquidity can be especially painful. A sharp market correction could depress multiple portfolio holdings simultaneously. Funds without robust liquidity constraints may face investor redemptions at precisely the moment their positions are least liquid.

Launching a new proxy contest under those conditions requires not only conviction in the target company’s value but also confidence in the broader macroeconomic environment. That confidence may be in short supply.

Will Shareholder Activism Decline?

A geopolitical crisis may temporarily pause — but will not eliminate — shareholder activism. There will always be structurally challenged companies, perceived governance failures, and missteps in capital allocation that attract activist attention.

However, activists may defer campaigns during a market downturn. They may also be more open to reasonable settlement terms and prefer an amicable resolution over a costly contest during a period of market instability. Moreover, shareholders may be less inclined to support disruptive governance changes in the midst of a geopolitical crisis, particularly if the target company’s business is directly affected.

On the other hand, market dislocations often expose gaps between stock price and intrinsic value. Companies that seemed average in a bull market may appear significantly worse managed during a downturn, as operational weaknesses masked by strong market conditions come to light.

If the Iran conflict stabilizes — or markets acclimate to the new risk premium — activists may reemerge with renewed intensity, armed with

• equity stakes acquired at lower prices,

• sharper arguments regarding relative performance, and/or

• fresh critiques of crisis management and risk oversight.

Much like the rebound seen during the Covid-19 pandemic or after “Liberation Day” in 2025, the Iran war may delay activism in the short term while setting the stage for a more aggressive fall season. This is particularly true for companies with off-cycle annual meetings.

Conclusion

The Iran war may function as a short-term poison pill for proxy contests — not because it strengthens corporate defenses but because it increases the risks associated with activist commitments.

Geopolitical uncertainty makes it harder for activists to underwrite multiyear positions, particularly when they face constrained trading flexibility and portfolio concentration that further magnify downside risk.

But history teaches that volatility rarely suppresses shareholder activism for long. If anything, it reshapes the battlefield.

Companies that use this period to strengthen governance, sharpen strategy, and fortify resilience will be better positioned for an activist’s inevitable return.